Express Scripts SVP Harold Carter on GLP-1s & the Future of Pharmacy Benefits (Repost)

Express Scripts SVP Harold Carter on GLP-1s & the Future of Pharmacy Benefits (Repost)

July 7, 2026 · 42 min

About this episode

Harold Carter discusses the impact of GLP-1 therapies on pharmacy benefits and the future of healthcare.

GLP-1 therapies are transforming pharmacy benefits, and Express Scripts is leading the way. Harold Carter, PharmD, SVP of Trade Relations, joins host Eric Glazer to discuss how one of the nation's largest PBMs is navigating this disruptive moment in healthcare. Harold shares how Express Scripts is: Capping costs of GLP-1 therapies to expand patient access while keeping plan spending predictable. Redesigning funding models to strike a balance between affordability, predictability, and outcomes. Leveraging digital tools and AI to reduce friction in the member experience and support long-term adherence. Rethinking formularies not just as cost-control tools but as part of a broader population health and behavioral change ecosystem. You'll also hear his forward-looking perspective on how PBMs will evolve over the next three to five years, and the key questions health plans and employers should be asking today to prepare for the future of pharmacy benefits. About Dr. Harold Carter: Harold Carter, PharmD, is responsible for leading all interactions and contracting with pharmaceutical manufacturers and oversees strategy and management of Express Scripts' drug formularies, data &…

People in this episode

Host: Eric Glazer

Guest: Harold Carter

Mentioned in this episode

Organizations: Express Scripts

Products: GLP-1 therapies

More episodes of Bright Spots in Healthcare

Explore listener stats, chart rankings, contacts and more on the Bright Spots in Healthcare podcast page.